Unlock instant, AI-driven research and patent intelligence for your innovation.

Crystal forms and synthetic methods of (2r,6r)-hydroxynorketamine and (2s,6s)-hydroxynorketamine

A technology of methylketamine crystallization, methylketamine, applied in bipolar depression, severe depression, standard treatment of selective 5-hydroxyl, and other depression and anxiety, recrystallization of 2R, 6R-HNK hydrochloride , the crystal form field of hydrochloride, which can solve problems such as no response

Active Publication Date: 2022-07-26
UNITED STATES OF AMERICA +1
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, some patients respond to the antidepressant effects of ketamine but not to SSRIs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal forms and synthetic methods of (2r,6r)-hydroxynorketamine and (2s,6s)-hydroxynorketamine
  • Crystal forms and synthetic methods of (2r,6r)-hydroxynorketamine and (2s,6s)-hydroxynorketamine
  • Crystal forms and synthetic methods of (2r,6r)-hydroxynorketamine and (2s,6s)-hydroxynorketamine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0157] Example 1. Chiral resolution of (S)-(+)-norketamine (14)

[0158]

[0159] Racemic norketamine (22.7 g, 101 mmol) (Cayman Chemicals, Ann Arbor, MI, USA, prepared as described in Hong, S.C. & Davisson, J.N., J.Pharm.Sci. (1982) 71:912-914) Dissolve in 1.1L ethanol. Then (D)-(R)-(+)-pyroglutamic acid solid (15.8 g, 0.5 equiv, 121 mmol) was added. The reaction was stirred and heated to reflux for 5 minutes. A white suspension formed while heating. Once the suspension reached reflux, it was allowed to cool to room temperature while stirring for 16 hours. The reaction was filtered and the white solid was collected. The resulting white solid was then resuspended in 0.9 L of ethanol, and the suspension was heated to reflux for 5 minutes. The suspension was allowed to cool to room temperature over 2 hours while stirring. The solid was collected by filtration, then suspended a third time in ethanol (0.8 L), heated to reflux for 5 minutes, and then allowed to cool to roo...

Embodiment 2

[0160] Example 2. (R)-(-)-norketamine (14 A ) chiral resolution

[0161]

[0162] (R)-(-)-norketamine (14 A ) was produced in a similar manner to (S)-(+)-norketamine (2), except that (L)-(S)-(-)-pyroglutamic acid was used as the chiral resolving reagent instead of (D) -(R)-(+)-Pyroglutamic acid. Chiral HPLC: 98% ee. (Chiralpak AD, 60% ethanol in hexane, 1 mL / min, rt: 6.8 min.) [α] D 20 : (-)-75°(c1.0, H 2 O, L-pyroglutamate salt).

Embodiment 3

[0163] Example 3. Synthesis of (S)-tert-butyl(1-(2-chlorophenyl)-2-oxocyclohexyl)carbamate (15)

[0164]

[0165] To a solution of (S)-(+)-norketamine (14) (1.85 g, 8.27 mmol) in toluene (100 mL) was added potassium carbonate (3.43 g, 24.8 mmol) and BOC-anhydride (2.71 g, 12.4 mmol) mmol). The reaction was heated to 80°C and stirred for 16 hours. The reaction was then cooled, extracted with ethyl acetate and washed with water. The organic layer was extracted and the solvent was removed in vacuo to give the crude product. Purification by silica gel chromatography (0% to 60% ethyl acetate in hexanes) gave the final product (15) as a white solid.

[0166] 1 H NMR (400MHz, CDCl 3 )δ7.83(d, J=8.0Hz, 1H), 7.42-7.28(m, 2H), 7.28-7.13(m, 1H), 6.59(s, 1H), 3.83(d, J=14.3Hz, 1H) ), 2.45-2.36 (m, 1H), 2.36-2.25 (m, 1H), 2.04 (ddq, J=11.5, 5.5, 3.0Hz, 1H), 1.89-1.56 (m, 4H), 1.29 (s, 9H) ).

[0167] 13 C NMR (101 MHz, CDCl 3 ) delta 209.0, 153.4, 135.1, 133.7, 131.5, 130.9, 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
optical rotationaaaaaaaaaa
Login to View More

Abstract

The present disclosure provides methods for the synthesis of (2R,6R)-hydroxynorketamine (HNK) and (2S,6S)-hydroxynorketamine in free base form. In one embodiment, the synthesis of (2R,6R)-hydroxynorketamine (HNK) comprises preparation by chiral resolution from racemic norketamine by chiral resolution using L-pyroglutamic acid (R)-norketamine. The present disclosure also provides corresponding crystalline forms of (2R,6R)-hydroxynorketamine (HNK) hydrochloride and (2S,6S)-hydroxynorketamine hydrochloride.

Description

[0001] Citations for Relevant Applications [0002] This application claims priority to U.S. Provisional Application No. 62 / 313,309, filed with the U.S. Patent and Trademark Office on March 25, 2016, and all rights acquired thereunder under 35 U.S.C. § 119, the contents of which are incorporated herein by reference in their entirety . [0003] Statement of Government Support [0004] This invention was made with government support under Grant No. NH099345 awarded by the National Institutes of Health. The US Government has certain rights in this invention. Background technique [0005] Ketamine is a drug currently used in human anesthesia and veterinary medicine that has been shown in clinical studies to be effective in treating a variety of conditions, including pain, treatment-resistant bipolar depression, major depressive disorder, and other depression and anxiety disorders related diseases. [0006] However, the routine use of this drug can be affected by undesired cent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C225/22A61K31/133
CPCC07C221/00C07C269/04C07C2601/14C07B2200/07C07C271/24C07C225/20C07C269/06C07C2601/16C07B2200/13
Inventor 克雷格·托马斯帕特里克·莫里斯卡洛斯·萨拉特鲁因·莫阿德尔托德·古尔德帕诺斯·萨诺斯
Owner UNITED STATES OF AMERICA